143 related articles for article (PubMed ID: 8743597)
1. Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol.
Kivastik T; Vuorikallas K; Piepponen TP; Zharkovsky A; Ahtee L
Pharmacol Biochem Behav; 1996 Jun; 54(2):371-5. PubMed ID: 8743597
[TBL] [Abstract][Full Text] [Related]
2. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat.
Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani AH
Pharmacol Biochem Behav; 2002 Dec; 74(1):187-97. PubMed ID: 12376167
[TBL] [Abstract][Full Text] [Related]
3. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.
Shippenberg TS; LeFevour A; Thompson AC
Eur J Pharmacol; 1998 Mar; 345(1):27-34. PubMed ID: 9593590
[TBL] [Abstract][Full Text] [Related]
5. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine.
Singh ME; Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Nov; 1026(2):244-53. PubMed ID: 15488486
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning.
Mackey WB; van der Kooy D
Pharmacol Biochem Behav; 1985 Jan; 22(1):101-5. PubMed ID: 2858106
[TBL] [Abstract][Full Text] [Related]
7. Initial d2 dopamine receptor sensitivity predicts cocaine sensitivity and reward in rats.
Merritt KE; Bachtell RK
PLoS One; 2013; 8(11):e78258. PubMed ID: 24223783
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference.
Zarrindast MR; Azami BN; Rostami P; Rezayof A
Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879
[TBL] [Abstract][Full Text] [Related]
9. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice.
Nakagawa T; Fujio M; Ozawa T; Minami M; Satoh M
Behav Brain Res; 2005 Jan; 156(2):233-9. PubMed ID: 15582109
[TBL] [Abstract][Full Text] [Related]
10. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference.
Francès H; Smirnova M; Leriche L; Sokoloff P
Psychopharmacology (Berl); 2004 Sep; 175(2):127-33. PubMed ID: 15095031
[TBL] [Abstract][Full Text] [Related]
12. Adrenalectomy potentiates the morphine--but not cocaine-induced place preference in rats.
Suzuki T; Sugano Y; Funada M; Misawa M
Life Sci; 1995 Mar; 56(17):PL339-44. PubMed ID: 8847945
[TBL] [Abstract][Full Text] [Related]
13. Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine- and cocaine-induced place preference.
Kotlińska J; Biała G
Pol J Pharmacol; 1999; 51(4):323-30. PubMed ID: 10540964
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of dopaminergic agents in the dorsal hippocampus and morphine-induced place preference.
Zarrindast MR; Nasehi M; Rostami P; Rezayof A; Fazli-Tabaei S
Behav Pharmacol; 2005 Mar; 16(2):85-92. PubMed ID: 15767843
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to the rewarding effects of the specific dopamine uptake inhibitor GBR12783.
Le Pen G; Duterte-Boucher D; Costentin J
J Pharmacol Exp Ther; 1998 Aug; 286(2):688-96. PubMed ID: 9694922
[TBL] [Abstract][Full Text] [Related]
16. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.
Rouge-Pont F; Usiello A; Benoit-Marand M; Gonon F; Piazza PV; Borrelli E
J Neurosci; 2002 Apr; 22(8):3293-301. PubMed ID: 11943831
[TBL] [Abstract][Full Text] [Related]
17. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
[TBL] [Abstract][Full Text] [Related]
18. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
[TBL] [Abstract][Full Text] [Related]
19. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
Rodríguez De Fonseca F; Rubio P; Martín-Calderón JL; Caine SB; Koob GF; Navarro M
Eur J Pharmacol; 1995 Feb; 274(1-3):47-55. PubMed ID: 7768280
[TBL] [Abstract][Full Text] [Related]
20. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine.
Suzuki T; Kishimoto Y; Misawa M
Life Sci; 1996; 59(19):1667-74. PubMed ID: 8913332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]